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Abstract 
The European Heart Journal – Cardiovascular Imaging has become one of the leading 
multimodality cardiovascular imaging journal since it was launched in 2012. The impact factor is 
an impressive 8.366 and it is now established as one of the top 10 cardiovascular journals. The 
journal is the most important cardiovascular imaging journal in Europe.  
The most important studies from 2018 will be highlighted in 2 reports. Part I of the review 
will focus on studies about myocardial function and risk prediction, myocardial ischaemia, and 
emerging techniques in cardiovascular imaging, while Part II will focus on valvular heart disease, 
heart failure, cardiomyopathies, and congenital heart disease. 
 
  
European Heart Journal – Cardiovascular Imaging has successfully consolidated as a 
multimodality journal during its first 7 years. The journal is now in the top 10 of all 
cardiovascular journals according to the recent 2017 impact factor ratings. It has now an 
important role as a significant resource for cardiologists, specialists in all imaging modalities, and 
other physicians working in the field of cardiovascular imaging. The tradition of highlighting the 
most important studies that were published in the last year is continued.1,2 In two articles, we will 
summarize the most important papers from the journal in 2018. Part I will focus on myocardial 
function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular 
imaging. 
Recommendations and expert consensus documents from the European 
Association of Cardiovascular Imaging 
One important assignment of European Heart Journal – Cardiovascular Imaging is to 
publish position papers, recommendations and expert consensus papers from the European 
Association of Cardiovascular Imaging (EACVI). The journal published 6 recommendations and 
expert consensus papers in the field of multimodality imaging.3–8 These papers are commented on 
in more detail elsewhere in the two documents. 
 
Myocardial function and risk prediction 
Hong and coworkers investigated 21 patients with invasive left ventricular (LV) pressure 
measurements and simultaneous echocardiography at rest and during submaximal supine bicycle 
exercise. LV apical back-rotation parameters by speckle-tracking echocardiography at rest and 
during 50 W of exercise were compared. Lack of decrease in minimal LV pressure during 
exercise, a manifestation of impaired LV suction in early diastole, was linked with impaired LV 
apical back rotation during exercise. Dynamic changes in LV apical back rotation during exercise 
can be used as a non-invasive parameter of diastolic suction during exercise.9 This paper was 
commented on by Dr. Smiseth, emphasizing that untwisting velocity may help to identify patients 
with severely impaired diastolic function during exercise. However, the small size of the study 
essentially demonstrated a mechanistic principle.10  
Bergerot and coauthors explored diastolic function changes over time in 310 patients with 
type 2 diabetes without overt heart disease to identify predictive factors of diastolic function 
deterioration. Diastolic function was assessed by echocardiography at baseline and 3-year follow-
up. Age, retinopathy, and increase in blood pressure over time were associated with an increased 
risk of diastolic function deterioration in type 2 diabetes patients.11  
Lee et al investigated the longitudinal relation between changes in body mass index 
(BMI) and LV diastolic function. They retrospectively identified 165 asymptomatic individuals 
with preserved LV ejection fraction, who underwent repeated health check-ups (median interval: 
365 days). They showed an association between changes in BMI and LV diastolic function. A 
decrease in BMI corresponded to a significant decrease in left atrial (LA) volume index and a 
significant increase in Doppler imaging peak diastolic (eʹ) velocity.12 
Hubert et al investigated if atrial remodelling occurring at early stage might predict atrial 
fibrillation (AF) in veteran athletes. Twenty-seven male endurance veteran athletes with 
documented paroxysmal AF were retrospectively enrolled and compared with 30 control 
endurance athletes without documented AF, with similar training level, age, and cardiovascular 
risk factors. All subjects underwent echocardiography, to evaluate the left and right atrial 
anatomical and functional remodelling assessed by two-dimensional (2D) strain. Atrial function 
was strongly associated with paroxysmal AF and was proposed to identify male endurance 
veteran athletes at risk to develop AF.13  
Rehman et al assessed whether resting right ventricular (RV) function assessed by Global 
RV longitudinal strain (RVLS) and RV fractional area change (FAC) was associated with 
exercise performance in pulmonary arterial hypertension (PAH) and in chronic thromboembolic 
pulmonary hypertension (CTEPH). They prospectively recruited 46 consecutive patients with 
PAH and 42 patients with CTEPH who were referred for cardio-pulmonary exercise testing and 
transthoracic echocardiography. In PAH, resting RV function was associated with exercise 
performance and could therefore make a significant contribution to non-invasive assessment in 
PAH patients. This association was not found in CTEPH, suggesting a disconnection between 
resting RV function and exercise performance, with implications for the use of exercise 
measurements as a prognostic marker and clinical/research endpoint in CTEPH.14  
Chowdhury et al assessed the validity of echocardiographic indices of LV systolic 
function via direct comparison to a novel composite measure of contractility derived from 
pressure–volume loop (PVL) analysis. Children with normal loading conditions undergoing 
routine left heart catheterization were prospectively enrolled. Pressure–volume loops were 
obtained via conductance catheters and systolic function was measured by speckle-tracking 
echocardiography. A composite invasive composite contractility index (ICCI) was developed 
using data reduction strategies to combine four measures of contractility derived from PVL 
analysis. Speckle-tracking derived longitudinal strain was associated the invasive composite 
contractility index in children with normal loading conditions and they concluded that 
longitudinal measures of deformation appeared to accurately assess LV contractility in children.15  
The EACVI/ASE/Industry Task Force to standardize deformation imaging prepared a 
consensus document to standardize definitions and techniques for using two-dimensional (2D) 
speckle tracking echocardiography (STE) to assess left atrial, right ventricular, and right atrial 
myocardial deformation. The document aimed to represent a step forward in the collaboration 
between the scientific societies and the industry since technical specifications of the software 
packages designed to post-process echocardiographic datasets have been agreed and shared 
before their actual development. The consensus aimed for more clinically oriented software 
packages which will be better tailored to clinical needs and will allow industry to save time and 
resources in their development.7  
Co-workers from the NORRE study (Normal Reference Ranges for Echocardiography) 
obtained the normal ranges for echocardiographic measurements of LA function from a large 
group of healthy volunteers accounting for age and gender. A total of 371 healthy subjects were 
enrolled at 22 collaborating institutions. Left atrial data sets were analysed with a vendor-
independent software package allowing homogeneous measurements irrespective of the 
echocardiographic equipment used to acquire data sets. The presented data highlight the 
importance of age-specific reference values for LA functions.16  
Semi-supine bicycle ergometry stress echocardiography was used to evaluate RV systolic 
and diastolic reserve in 39 paediatric heart transplantation (HTx) recipients and 23 controls. 
Colour tissue Doppler imaging (TDI) peak systolic (s’) and e’ velocities, myocardial acceleration 
during isovolumic contraction (IVA), and RV free wall longitudinal strain were measured at 
incremental heart rates. RV systolic and diastolic functional response to exercise was preserved 
with a normal increase in TDI velocities and strain values with increasing heart rate. There was a 
blunted IVA response possibly indicating a mildly decreased RV contractile response which 
requires further investigation.17  
Almeida et al evaluated the impact of the recent 2016 American Society of 
Echocardiography (ASE)/European Association of Cardiovascular Imaging (EACVI) 
recommendations in the prevalence and grades of diastolic dysfunction compared with the 2009 
guidelines and the Canberra Study Criteria. A population-based cohort of a total of 1000 
individuals, aged ≥45 years, were evaluated retrospectively. Diastolic function was assessed by 
transthoracic echocardiography. The application of the new 2016 ASE/EACVI recommendations 
resulted in a much lower prevalence of diastolic dysfunction and the concordance between the 
classifications was poor. The updated algorithm seemed to be able to diagnose only the most 
advanced cases.18  
The study was commented on by Drs. Edvardsen and Smiseth. They pointed out that the 
recommendations in the recent EACVI/ASE guideline suggesting echocardiographic indices of 
LV diastolic function to be used to identify patients with elevated LV filling pressure have been 
confirmed in two large multicentre validation studies. This represents a major step forward in 
echocardiographic evaluation of diastolic function. The issue of optimal combination of diastolic 
function indices to grade diastolic function and to differentiate between normal and abnormal 
diastolic function needs further elaboration. They concluded that rather than more expert 
opinions, there is need for studies which relate different filling patterns and more novel 
classification schemes to clinical outcome.19  
Park et al investigated the association between alcohol consumption and LV functional 
and structural abnormality. Study participants were 49 714 Korean adults undergoing 
echocardiogram during a health check-up program and they were stratified into 6 groups 
according to alcohol consumption. Increased alcohol intake had adverse effect on LV function 
and structure. Potential favourable effect of light alcohol intake was not observed.20  
Gorter et al studied the value of echocardiographic right-sided characterization for the 
discrimination between pre- vs. post-capillary pulmonary hypertension in heart failure with 
preserved ejection fraction (HFpEF), using invasive haemodynamics as gold standard. A total of 
102 consecutive HFpEF patients with simultaneous right heart catheterization and 
echocardiography were identified. Abnormal right ventricular-vascular coupling identified 
patients with HFpEF and additional pre-capillary pulmonary hypertension and predicted poor 
outcome in HFpEF.21  
Saito et al investigated the prognostic value of LV and RV deformation in 103 patients 
with systemic sclerosis and 103 age- and gender-matched controls. Speckle tracking LV strain 
parameters including global longitudinal strain (GLS) and global circumferential strain (GCS), 
and tricuspid annular peak systolic velocity (Ts′) were measured. Subjects were followed for a 
median of 3.4 years for heart failure-specific admission or death. RV dysfunction was associated 
with adverse outcome, independent of and incremental to clinical and LV deformation 
parameters. LV dysfunction appeared to have less prognostic relevance than RV dysfunction.22  
Risum et al investigated the importance of RV function for prediction of sudden cardiac 
death (SCD) or malignant ventricular arrhythmias (VAs) after acute myocardial infarction in 790 
prospectively included patients with acute MI. All patients had 2D strain echocardiography 
performed to evaluate right ventricular (RV) free wall strain (RVS) and RV mechanical 
dispersion (MD). RVS, but not RV MD, was significantly and independently related to SCD/VA 
in patients with acute MI. Furthermore, RVS was shown to be superior to TAPSE.23  
Fung et al examined 129 patients of which 73 had hypertension with dobutamine 
echocardiography. LV ejection fraction (LVEF), global longitudinal strain (GLS), 
circumferential, and radial strain were measured at rest and at low-dose dobutamine. Compared 
with controls, hypertensive patients had impaired LV GLS at rest and impaired contractile 
reserve despite normal LVEF. Impaired contractile reserve correlated with LV wall thickness but 
independent of prevailing blood pressure.24  
Hilbert and colleagues provided further important evidence of the feasibility - with 
regards to safety and diagnostic image quality - for performing CMR in patients with cardiac 
implantable electronic devices.25 Device type and location were the main determinants of image 
quality with implantable cardioverter defibrillators demonstrating the largest impact. Post-
contrast spoiled gradient echo sequences were of higher quality in such patients compared with 
the steady state free precession (SSFP) cine imaging for assessment of cardiac volumes and 
function. 
Differentiation of normal from pathological cardiac remodelling still remains challenging 
clinically despite years of research and progress. Claessen and colleagues reported the potential 
for exercise CMR to address the problem of differentiating athlete’s hearts from pathological LV 
dilatation and mildly reduced LV systolic function.26 The LV ejection fraction change due to 
exercise was dampened in dilated cardiomyopathy patients and endurance athletes with 
myocardial fibrosis when compared to endurance athletes without myocardial fibrosis. 
CMR has the ability to provide information that can lead to change in management in 
70% of patients with thalassaemia major due to its ability to determine chamber sizes and 
function, myocardial fibrosis and myocardial iron overload determined by T2* measurements. In 
addition, as shown by Pepe and colleagues, myocardial fibrosis, myocardial iron overload and 
ventricular dysfunction were independent predictors of heart failure in thalassaemia major 
patients.27 
 
Ischaemic heart disease 
 
Ischaemic heart disease remains an important subject for imagers and multimodality 
imaging is frequently needed.28,29  Echocardiography remains clinically significant and important 
prognostic markers can be reported just after and during the follow-up of patients treated for an 
acute myocardial infarction.30 (Figure 1) 
Strain data are encouraged by several studies despite the fact that we miss strong evidence 
that might change the treatment. Twist, torsion, and strain have been reported as more reduced in 
heart failure patients compared to controls. Torsion and twist are significantly lower in patients 
with non-ischaeic compared to ischaeic cardiomyopathies, despite similar volumetric dimensions, 
circumferential and longitudinal strain parameters, and LVEF. These torsion and rotation patterns 
could be considered more carefully in future studies for best characterizing the LV dysfunction 
according to the aetiology31,32. The additive value of strain data in diabetic patients has been 
reported and will probably be recommended in the future for the assessment of the myocardium 
of diabetic patients33–35. 
Among patients with ST-segment elevation myocardial infarction (STEMI), the presence 
of chronic obstructive pulmonary disease (COPD) has been independently associated with higher 
mortality when compared with patients without COPD. LV systolic function is a known 
prognostic factor after ST-segment elevation myocardial infarction but impaired LV GLS is 
independently associated with worse long-term survival in STEMI patients. 143 patients with an 
acute myocardial infarction were retrospectively included, and 66 (46%) patients died and 70 
(49%) patients reached the combined endpoint after a median follow-up of 68 months. Patients 
with LV GLS >-14.4% (more impaired) showed higher cumulative event rates of all-cause 
mortality.36 
The consequences of myocardial infarction on mitral valve apparatus are important to 
consider and a proper understanding of the relationship between the injured myocardium and the 
mitral valve apparatus might impact the management of the patient.37 38 39 Mechanisms of chronic 
ischaemic mitral regurgitation (IMR) are well-characterized by apically tethered leaflet caused by 
papillary muscles (PMs) displacement and adynamic mitral apparatus.39 But, using 3D 
echocardiography of patients with first MI, it has been provided insights into unique 3D 
dynamics of the mitral apparatus in acute IMR.40 Mitral plasticity is a compensatory mechanism 
that allows the mitral valve to increase its total area and generate a larger coaptation zone, and 
therefore, decrease and potentially prevent ischaemic mitral regurgitation. This is affected by the 
post MI remodelling, but it has also been shown that clinical features have to be considered. 
Authors found that longer time-duration of diabetes mellitus and higher haemoglobin levels were 
independently associated with development of mitral plasticity.39 This is fascinating and might 
impact our clinical management.  
Coronary computed tomography angiography (CTA) with its excellent sensitivity and 
negative predictive value is a reliable non-invasive imaging tool to rule out obstructive coronary 
artery disease. Advancements in image reconstruction algorithms, detector architecture, and post-
processing tools further increased the ability to assess coronary atherosclerotic plaques and 
provide important prognostic information. The mismatch between coronary artery stenosis grade 
and ischaemia is well known, and it is reflected by the limited specificity and positive predictive 
value of coronary CTA to identify haemodynamically relevant coronary lesions. Different 
methods have been introduced to overcome this clinically important limitation. The two main and 
most robust approaches to add functional dimension to this anatomical imaging technique are the 
computed tomography (CT)-based simulation of fractional flow reserve (FFR) and CT perfusion 
imaging (CTP). These techniques are complementary to anatomical CT imaging and are able to 
enhance the diagnostic performance by increasing positive predictive value and specificity and 
consequently reducing unnecessary downstream testing. 
Detecting ischaemia is crucial to guide clinical decision making particularly among 
patients with at least moderate stenosis (above 50%). The simulation of FFR is based on 
conventionally acquired coronary CTA images, however, its use is still limited mainly due to the 
associated high costs and the necessity to send whole CT data sets to an offsite location to 
perform the computer intense haemodynamic simulations. CTP requires pharmacologic stressor 
agents and additional imaging either using static or dynamic acquisition protocols. However its 
results are instantly available for the referring physicians. 
To compare the diagnostic performance of a reduced-order computed tomography-derived 
fractional flow reserve (CT-FFR) technique derived from luminal deformation and static CT 
stress myocardial perfusion (CTP), Ihdayhid and colleagues prospectively enrolled 46 patients 
(84 vessels) with suspected coronary artery disease from a single institution planned for elective 
coronary angiography. They underwent research indicated invasive FFR and 320-detector CT 
coronary angiography (CTA) and static CTP.41 The authors demonstrated that in patients with 
suspected coronary artery disease, a reduced-order CT-FFR technique can identify lesion specific 
ischaemia with high accuracy compared with FFR; and is superior to CTA and static CTP 
assessed visually and quantitatively, in a per-vessel and per-patient analysis. Based on this 
selected cohort of patients, CT-FFR had superior incremental diagnostic value when added to 
CTA for identifying functionally significant stenosis as assessed by FFR when compared with 
CTP. Importantly, the benefit of CT-FFR was delivered using a standard desktop computer from 
a single widened acquisition CTA, without the need for additional medications and with reduced 
contrast and radiation exposure compared with CTP. (Figure 2) 
However, larger prospective studies in an intermediate risk population will be required to 
further assess the real-world feasibility of this CT-FFR technique.  
Another important study, that underlined the big effort around these themes, was published by 
Pontone et al. 42.  Aim of this study was to further elucidate the ability of static stress CTP to 
increase diagnostic performance when compared with coronary CTA using on one hand the 
visual assessment of ischaeia and on the other hand the calculation of transmural perfusion ratio 
(TPR). The investigators enrolled 88 symptomatic patients with high pre-test probability who 
were referred for invasive angiography and FFR measurement. The prevalence of obstructive 
CAD and functionally significant CAD were 71% and 48%, respectively. The Authors concluded 
that adding cCTA to CTP with either qualitative or quantitative evaluation has good accuracy for 
detecting functionally significant CAD. However, TPR evaluation is associated with a trend 
towards lower specificity, positive predictive, and diagnostic accuracy when compared with 
cCTA plus CTP with qualitative evaluation and is more time consuming. Thus, a protocol 
integrating anatomy and functional assessment using the latest-generation scanner is feasible, and 
provides fast and simple qualitative evaluation of myocardial perfusion allowing reliable 
detection of functionally significant CAD.  
Finally, the use of CT-FFR can be an effective to technique for the rule out of patients 
with typical angina pectoris. To assess the use of downstream coronary angiography (ICA) and 
short-term safety of frontline CTA with CT-FFR testing in stable patients with typical angina 
pectoris, 774 patients referred to non-emergent ICA or coronary CTA at Aarhus University 
Hospital on a suspicion of CAD were enrolled and downstream testing and treatment within 3 
months and adverse events ≥ 90 days were registered. 43 In the high- vs. low-intermediate-risk 
group, ICA was cancelled in 75% vs. 91%. Coronary revascularization was performed more 
frequently in high-risk than in low-intermediate-risk patients, 76% vs. 52% (P = 0.03). Serious 
clinical events occurred in four patients, but not in any patients with cancelled ICA by coronary 
CTA with selective CT-FFR testing. The authors concluded that frontline coronary CTA with 
selective CT-FFR testing in stable patients with typical angina pectoris in real-world practice is 
associated with a high rate of safe cancellation of planned ICAs.  
Coronary CT can be used also to examine the association between coronary artery 
calcium score (CACS) and risk of future AF, and to estimate the predictive accuracy of CACS for 
AF development in patients undergoing non-contrast cardiac computed tomography (nCCT). 
In the study published by Vinter et al, a Danish registry-based cohort study, 27 962 
patients were followed until 2016 (median 2.9 years).44 The authors concluded that a high CACS 
was associated with a high risk of AF and that the relationship between the two parameters was 
such that an individual’s risk of AF increased as the CACS increased, even after multivariable 
adjustment. They also demonstrated that CACS had moderate predictive accuracy with respect to 
identifying individuals at risk for developing AF within one year after nCCT. CACS combined 
with knowledge regarding other AF risk factors may help clinicians to identify patients at high 
risk for AF, which may facilitate both disease prevention and earlier treatment of patients who 
most likely develop AF and thus reduce their risk of stroke. 
The role of myocardial perfusion scintigraphy (MPS) in the evaluation of patient with 
known or suspected CAD is well known. However, there are some points that need to be 
underlined or clarified.  
Single-photon emission computed tomography (SPECT) is widely used for the 
assessment of coronary artery disease and for decision-making regarding revascularization, even 
if concerns about possible false negative findings exist.  
Yokota et al aimed to assess the prevalence of stenoses which are both functionally and 
anatomically significant in 133 patients referred for invasive FFR measurements following a 
normal SPECT, because of persistent complaints.45 If FFR <0.75 was used, only 7.5% of the 
patients had both anatomically and functionally significant stenoses. In patients with normal 
SPECT who undergo FFR measurements because of persistent complaints, the prevalence of 
stenoses which are of both anatomically and functionally significant is low. This suggests that the 
prevalence of false-negative SPECT is (very) low. 
The Dan-NICAD trial, an open label, parallel, head to head, randomized controlled 
diagnostic accuracy trial of CMR and myocardial perfusion scintigraphy showed disappointing 
diagnostic accuracy for both techniques. In this work by Nissen and colleagues these functional 
tests were performed in patients at low to intermediate risk of obstructive coronary artery disease 
following a positive coronary CT angiography.46 These patients may represent a particular 
challenge to perfusion techniques and further research to better understand the underlying 
mechanisms is needed. 
In order to increase the sensitivity of SPECT, the appropriate choice of stress modality, 
especially in difficult population, is mandatory. To this end, Gimelli and colleagues compared the 
impact of exercise stress test versus vasodilator test in patients with diabetes mellitus, matched 
with a control group.47 In patients with DM exercise stress SPECT had a lower accuracy than 
vasodilator-stress (AUC 0.70 vs. 0.89, P < 0.001), because of a lower specificity (45% vs. 69%), 
while in the control group the accuracy of MPS was similar regardless of the stress-protocol 
adopted. So, even if the accuracy of MPS in patients with DM is elevated, a reduced specificity 
can be expected in the case of exercise stress MPS, because of an impaired exercise capacity. 
Finally, nuclear cardiology can be used for the evaluation not only of contractile reserve, 
but also of chronotropic response in patients with reduced left ventricular ejection fraction. 48 
Tamarappoo et al evaluated, by Rubidium-82 gated PET, the independent prognostic value of 
inadequate heart rate reserve and ejection fraction in response to pharmacologic stress in a high-
risk group of 461 patients with reduced resting LVEF. The Authors concluded that resting heart 
rate, inadequate heart rate reserve and ejection fraction were prognostically important in 
predicting all cause of death after accounting for clinically important risk factors. The relative 
importance these variables in affecting all cause of death were dependent upon age. A significant 
inadequate heart rate reserve was relatively more important than reduced ejection fraction reserve 
for improved survival among young patients, with the exception of older patients. 
 
 Emerging techniques 
In the field of echocardiography new techniques have been recently developed and some 
older ones proved their clinical utility in new clinical settings. 
Myocardial work (estimated by pressure-strain loops) was studied for the identification of 
responders to cardiac resynchronization therapy (CRT). Galli et al have assessed 97 patients with 
symptomatic heart failure (ejection fraction: 27 ± 6%, QRS duration 164 ± 18 ms) undergoing 
CRT. Patients with higher myocardial work (>1057 mmHg%) exhibited a favourable response to 
CRT, predicting a >15% reduction in left ventricular (LV) end-systolic volume at 6 months 
follow up in both ischaemic and non-ischaemic aetiology. 49 
In patients with acute coronary syndrome (ACS) layer-specific and global longitudinal 
strain (GLS) provide prognostic information regarding the risk of heart failure or cardiovascular 
death. Skaarup et al have studied 465 ACS patients treated by PCI, with a median follow-up time 
of 4.6 years. Endomyocardial GLS (12% vs 17%), global longitudinal strain (11% vs 14%), and 
epimyocardial GLS (9% vs. 13%) were all significantly reduced in patients with an adverse 
outcome. GLS and epimyocardial GLS provided incremental prognostic information when added 
to all other significant predictors in this setting. 50 
The echocardiographic-fluoroscopic fusion imaging is a new imaging system that 
facilitates catheters and device navigation during catheter-based structural heart disease 
interventions. The advantages and limitations of this novel imaging system during mitral valve 
transcatheter interventions are discussed in a comprehensive review by Faletra et al. 51 
Quantitative myocardial perfusion evaluated with positron emission tomography in the 
form of stress myocardial blood flow and myocardial flow reserve (MFR) is a prognostic factor 
for the development of major adverse cardiovascular outcomes (MACE) in populations with 
known or suspected coronary artery disease. Eight studies (n = 6804) were analysed in a 
systematic review. The pooling instance demonstrated that MFR significantly associates with the 
development of MACEs (HR: 1.92 [1.29, 2.84]; P = 0.001). Myocardial flow reserve seems to 
outperform stress myocardial blood flow as an independent prognostic factor. 52 
Optical frequency domain imaging (OFDI) is a new method used to assess fibroatheromas 
with the goal to identify coronary lesions precursors of acute events. In 49 patients, OFDI was 
performed following treatment of culprit lesion and at 6-month follow-up in patients with 
STEMI. Non-culprit fibroatheromas located in the infarct related artery of patients with acute 
coronary syndromes had a volumetric reduction of the fibrous cap at 6-month follow-up, and 
27% of the lesions changed their phenotype over time. Quantitative fibrous cap assessment was 
able to differentiate high-risk lesions that became thick cap fibroatheromas.53  
In another study, Shimokado et al. showed that short wavelength (1700 nm) infra-red 
optical coherence tomography accurately identified lipid tissue in coronary autopsy specimens 
with a positive predictive value and a negative predictive value of 97% and 74%, respectively. 
This new technique increases the possibility of identifying histopathological features of coronary 
plaques at risk for rupture.54  
Cao and colleagues derived central circulation transit time from first pass perfusion 
cardiovascular magnetic resonance (CMR) images. This transit time was determined as the time 
delay between the peaks of signal intensity curves normalised to the cardiac cycle length. The 
transit time between the right atrium and the ascending aorta was considered to be the global 
transit time, and regional transit times were between the right atrium and pulmonary artery or the 
pulmonary artery and left atrium, and the left atrium and ascending aorta. Prolongation of global 
and regional transit times were observed in patients with heart failure and reduced ejection 
fraction and patients with heart failure and preserved ejection fraction. Thus, determination of 
transit times is feasible using first pass perfusion CMR and may be an important biomarker in 
heart failure.55  
In some way similar to the transit times by Cao and colleagues was a method developed 
and described by Ricci and colleagues. Similar, as it also used first pass perfusion CMR and time 
delays between peaks of signal intensity curves. Ricci and colleagues called their biomarker 
pulmonary blood volume index (PBVI). PBVI equals the right ventricular stroke volume and the 
pulmonary transit time normalised by the body surface area. The pulmonary transit time is the 
time delay between the peak of the signal intensity curves in the right ventricle and the left 
atrium. This marker was determined in a cohort of chronic heart failure patients and healthy 
controls and PBVI was found to be higher in heart failure and was additionally found to be an 
independent predictor of a composite cardiovascular endpoint. 56 
In another MRI study Schäfer et al. showed that reduced vortices assessed by four-
dimensional flow CMR in the LV of patients with mild-to-moderate chronic obstructive pulmonary 
disease is a potential marker of early LV diastolic dysfunction and precede more obvious 
mechanical changes such as stiffening and dilatation. Reduced LV vortices appear to be driven by 
COPD-induced changes in lung tissue and parallel RV dysfunction. 57 
Hybrid positron emission tomography–magnetic resonance (PET/MR) imaging is a novel 
imaging modality with emerging applications for cardiovascular disease. It aims at combining the 
high-spatial resolution morphological and functional assessment afforded by MRI with the ability 
of PET for quantification of metabolism, perfusion, and inflammation. An overview of PET-MR 
technology and the clinical cardiovascular applications of PET and MRI performed separately 
and with hybrid PET-MR are presented in a comprehensive review by Nazir et al. 58 
Wicks and colleagues reported the complementary information provided by CMR and 
18F-flurodeoxyglucose (FDG)-positron emission tomography to diagnose cardiac sarcoidosis. In 
particular patients with late gadolinium enhancement and FDG uptake were at increased risk of 
adverse events.59 
 
Figure legends 
 
Figure 1. Scar in the infero-latero basal segment involving the papillary muscle and inducing a 
severe tethering on the posterior mitral leaflet (A); severe secondary mitral regurgitation (B); 
consequences on the longitudinal strain with a dyskinesia localized in the segment of the inferior 
papillary muscle (C). 
 
Figure 2 Coronary artery disease with positive CT-FFR and CTP. Forty-two-year-old man with 
increasing exertional chest pains and suspected coronary artery disease. CTA demonstrated 
moderate to severe stenosis (x) in the proximal LAD artery with further moderate disease in the 
mid-vessel (y) (A). Invasive coronary angiography (B) demonstrated moderate 40–50% stenosis 
in the proximal (x) and mid-segment (y) of the LAD. Invasive FFR was functionally significant 
at 0.75 in the distal vessel. CT-FFR (C) was functionally significant at 0.77 in the distal vessel. 
Visually assessed CTP identified perfusion defects in the anterior wall indicating LAD territory 
ischaemia (D). Transmural perfusion polar plot (E, F) demonstrating TPR values and abnormal 
perfusion in anterior wall. Orange colour indicates TPR values <0.94 and blue colour indicates 
TPR values >0.99. CT-FFR, CT-derived fractional flow reserve; CTA, CT coronary angiogram; 
CTP, CT stress myocardial perfusion imaging; FFR, fractional flow reserve; LAD, left anterior 
descending; TPR, transmural perfusion ratio. From Ihdayhid et al. 41 
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